SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001078782-20-000320
Filing Date
2020-05-13
Accepted
2020-05-12 21:29:40
Documents
3
Period of Report
2020-05-13
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8K CURRENT REPORT f8k051320_8k.htm 8-K 15958
2 EXHIBIT 99.1 PRESS RELEASE f8k051320_ex99z1.htm EX-99.1 35832
3 IMAGE f8k0513208k1.jpg GRAPHIC 28546
  Complete submission text file 0001078782-20-000320.txt   91890
Mailing Address 45 ROCKEFELLER PLAZA 20TH FLOOR, STE 83 NEW YORK NY 10022
Business Address 45 ROCKEFELLER PLAZA 20TH FLOOR, STE 83 NEW YORK NY 10022 (212) 751-0001
AXIM BIOTECHNOLOGIES, INC. (Filer) CIK: 0001514946 (see all company filings)

IRS No.: 274092986 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-54296 | Film No.: 20870816
SIC: 2834 Pharmaceutical Preparations